via Latest News
https://ift.tt/3n4FQ6A
Sharp re-rating has turned the stock into the most expensive in the pharma space
January 04, 2021 at 06:10AM
Limited near term gains for Syngene International stock in pharma space
Latest News
https://ift.tt/2LUVdkd
https://ift.tt/3n4FQ6A
Sharp re-rating has turned the stock into the most expensive in the pharma space
January 04, 2021 at 06:10AM
Limited near term gains for Syngene International stock in pharma space
Latest News
https://ift.tt/2LUVdkd
0 Comments